Global Point of Care
What challenges still exist in mild traumatic brain injury (mTBI) evaluation and management, as well as approaches to patient care? Join Dr. Chris Davlantes and Dr. Jamshid Ghajar as they review the current state of mTBI assessment and management, as well as new advancements in biomarker testing. They will also provide an overview of the current standard of care, tools and modalities, and discuss second impact syndrome.
This webinar is sponsored by Abbott and provided at no cost to attendees. Includes 1 ACBIS CEU.
Dr. Jamshid Ghajar
Clinical Professor of Neurosurgery, Stanford University
Dr. Chris Davlantes
Senior Director, Global Medical Affairs, Abbott
ED directors, ED physicians, pathology directors, lab directors, lab techs, nurse directors, nurses, neurologists, POC coordinators
A Leader in Rapid Point-of-Care Diagnostics.
©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.